Immatics (IMTX) Interest & Investment Income (2019 - 2025)

Immatics' (IMTX) quarterly Interest & Investment Income came in at -$15.9 million in Q3 2025, up 20.22% year-on-year from -$13.3 million in Q3 2024, and down 231.73% quarter-over-quarter from $12.1 million in Q2 2025.

Immatics (IMTX) Interest & Investment Income (2019 - 2025) Analysis & Trends

Immatics has disclosed Interest & Investment Income across 7 years of filings, most recently posting -$15.9 million for Q3 2025.

  • Interest & Investment Income for Q3 2025 came in at -$15.9 million, up 20.22% year-over-year; the trailing twelve-month figure through Sep 2025 was -$15.9 million (up 20.22% YoY), and the FY2025 annual result was $20.9 million, down 55.53% from the prior year.
  • Interest & Investment Income came in at -$15.9 million for Q3 2025 at Immatics, down from $12.1 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $16.8 million in Q3 2022 to a low of -$20.0 million in Q3 2024.
  • The 5-year median for Interest & Investment Income is -$81938.6 (2021), against an average of $966520.0.
  • Across the five-year window, Interest & Investment Income soared 14025.38% in 2022 and sank 35826.69% in 2023, its largest moves.
  • Immatics' Interest & Investment Income stood at -$152148.1 in 2021, then jumped by 11109.31% to $16.8 million in 2022, then dropped by 6.33% to $15.7 million in 2023, then slumped by 227.28% to -$20.0 million in 2024, then rose by 20.22% to -$15.9 million in 2025.
  • The last three Interest & Investment Income figures came in at -$15.9 million (Q3 2025), $12.1 million (Q2 2025), and -$5.7 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 597,319.59
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 40.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 305,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 103,341.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 114.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - -14.79 Mn
10 Immatics 14.67 Bn 14.67 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -15.93 Mn
Jun 30, 2025 12.09 Mn
Mar 31, 2025 -5.75 Mn
Sep 30, 2024 -19.97 Mn
Jun 30, 2024 -13.63 Mn
Mar 31, 2024 12.36 Mn
Sep 30, 2023 15.69 Mn
Jun 30, 2023 7.35 Mn
Mar 31, 2023 -2.42 Mn
Sep 30, 2022 16.75 Mn
Jun 30, 2022 9.36 Mn
Mar 31, 2022 -6,734.03
Dec 31, 2021 -152,148.14
Sep 30, 2021 -120,287.31
Jun 30, 2021 -104,771.62
Mar 31, 2021 -59,105.57
Dec 31, 2020 3.52 Mn
Sep 30, 2020 -1.25 Mn
Jun 30, 2020 -831,602.40
Mar 31, 2020 -352,156.55